Gene editing treatments in general are prohibitively expensive (At least in the US). Casgevy cures sickle cell and beta-thallasemia but I want to say it costs $300,000? For the one dose.

You'd think insurance would jump on that given how much ER visits are, and the prevalence of ER visits in that patient demographic though.